Collaborative Group of the Americas on Inherited Gastrointestinal Cancer - CGA-IGC
About the organization
The Collaborative Group of Americas on Inherited Gastrointestinal Cancer (CGA-IGC) was established in 1995 to improve understanding of the basic science of inherited gastrointestinal cancer and the clinical management of affected families.
The CGA-IGC’s clinical and research focus is hereditary gastrointestinal cancer syndromes, including but not limited to:
Lynch Syndrome
Familial Adenomatous Polyposis (FAP)
Familial Pancreatic Cancer
Gastric Adenocarcinoma Proximal Polyposis of the Stomach (GAPPS)
Hereditary Diffuse Gastric Cancer
Hereditary Mixed Polyposis Syndrome
Juvenile Polyposis Syndrome
MUTYH Associated Polyposis (MAP)
Peutz-Jeghers Syndrome
Polymerase Proofreading-Associated Polyposis (PPAP)
PTEN Hamartoma Tumor Syndrome
Serrated Polyposis Syndrome
The vision of the CGA-IGC is to eliminate morbidity and early mortality of hereditary gastrointestinal cancers.
The mission of the CGA-IGC is to advance science and clinical care of inherited gastrointestinal cancers through research, education and patient advocacy as the leading authority in the Americas. Through this mission, the CGA-IGC offers the following:
Education regarding the clinical management and molecular genetics of inherited gastrointestinal cancer to physicians, allied healthcare professionals, patients, and their families
Access to collaborative trials and studies
Resources for developing new hereditary registries and supporting their registries
A forum for exchange of ideas
Multidisciplinary expertise in clinical care, healthcare policy, and research related to hereditary gastrointestinal cancer
The Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC) promotes diversity and inclusiveness throughout the organization including in its membership, governance, and education programming. The CGA-IGC also recognizes the importance of advancing health equity in patient care in achieving our core mission as an organization.
The CGA-IGC is committed to:
Fostering an environment that is inclusive of all groups including, but not limited to sex, race, ethnicity, gender identity, sexual orientation, religious beliefs, varying physical and mental abilities, professional specialty, and level of training.
Increasing diversity within the organization that mirrors the rich and heterogeneous skills and professions of the hereditary gastrointestinal cancer medical community.
Reducing disparities in health and healthcare and expanding research opportunities for patients and families at risk for gastrointestinal cancers.
The CGA-IGC is a community of over 400 clinicians, geneticists, researchers and patient advocates actively involved in our year-round society offerings, including continuing-education accredited webinars, monthly email journal scans and collaborative research meetings. Our wider network of over 1000 individuals includes scientific leaders and patient-advocacy organizations who receive regular communcation from our society via newsletters, and who are invited to participatein our open access resources including social media activities (such as Twitter Journal Clubs), patient education materials, research opportunities, and our podcast series (which has over 2000 listens/downloads).
Join CGA-IGC today and access our valuable membership benefits, including a discounted annual meeting registration rate.
The Collaborative Group of Americas on Inherited Gastrointestinal Cancer (CGA-IGC) was established in 1995 to improve understanding of the basic science of inherited gastrointestinal cancer and the clinical management of affected families.
The CGA-IGC’s clinical and research focus is hereditary gastrointestinal cancer syndromes, including but not limited to:
Lynch Syndrome
Familial Adenomatous Polyposis (FAP)
Familial Pancreatic Cancer
Gastric Adenocarcinoma Proximal Polyposis of the Stomach (GAPPS)
Hereditary Diffuse Gastric Cancer
Hereditary Mixed Polyposis Syndrome
Juvenile Polyposis Syndrome
MUTYH Associated Polyposis (MAP)
Peutz-Jeghers Syndrome
Polymerase Proofreading-Associated Polyposis (PPAP)
PTEN Hamartoma Tumor Syndrome
Serrated Polyposis Syndrome
The vision of the CGA-IGC is to eliminate morbidity and early mortality of hereditary gastrointestinal cancers.
The mission of the CGA-IGC is to advance science and clinical care of inherited gastrointestinal cancers through research, education and patient advocacy as the leading authority in the Americas. Through this mission, the CGA-IGC offers the following:
Education regarding the clinical management and molecular genetics of inherited gastrointestinal cancer to physicians, allied healthcare professionals, patients, and their families
Access to collaborative trials and studies
Resources for developing new hereditary registries and supporting their registries
A forum for exchange of ideas
Multidisciplinary expertise in clinical care, healthcare policy, and research related to hereditary gastrointestinal cancer
The Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC) promotes diversity and inclusiveness throughout the organization including in its membership, governance, and education programming. The CGA-IGC also recognizes the importance of advancing health equity in patient care in achieving our core mission as an organization.
The CGA-IGC is committed to:
Fostering an environment that is inclusive of all groups including, but not limited to sex, race, ethnicity, gender identity, sexual orientation, religious beliefs, varying physical and mental abilities, professional specialty, and level of training.
Increasing diversity within the organization that mirrors the rich and heterogeneous skills and professions of the hereditary gastrointestinal cancer medical community.
Reducing disparities in health and healthcare and expanding research opportunities for patients and families at risk for gastrointestinal cancers.
The CGA-IGC is a community of over 400 clinicians, geneticists, researchers and patient advocates actively involved in our year-round society offerings, including continuing-education accredited webinars, monthly email journal scans and collaborative research meetings. Our wider network of over 1000 individuals includes scientific leaders and patient-advocacy organizations who receive regular communcation from our society via newsletters, and who are invited to participatein our open access resources including social media activities (such as Twitter Journal Clubs), patient education materials, research opportunities, and our podcast series (which has over 2000 listens/downloads).
Join CGA-IGC today and access our valuable membership benefits, including a discounted annual meeting registration rate.
Past events
27th Annual Meeting of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC 2023) Thursday, October 26, 2023 - Saturday, October 28, 2023 | Las Vegas United States | Kenes Group
This is truly a can’t-miss meeting for genetic counselors, physicians, scientists, advanced practice providers, psychologists, nurses, patient advocates, and anyone else seeking state-of-the-art updates in the diagnosis and treatment of patients with hereditary gastrointestinal cancer syndromes.